PHANCY Group Co., Ltd. announced the completion of its H-share placement on 29 April 2026, issuing 38.80 million new H shares under the existing general mandate at HK$40.36 per share. The transaction, executed through a syndicate of placing agents, generated gross proceeds of approximately HK$1.57 billion.

The newly issued shares represent 12.09% of PHANCY’s H shares and 7.47% of total issued shares immediately before the placement. Upon completion, the company’s total share count rose to 558.48 million (from 519.68 million), with H shares increasing to 359.61 million, or 64.39% of the enlarged share capital; unlisted shares remained at 198.87 million, or 35.61%.

Ownership structure shifted modestly. Chairman and CEO Dr. Dai Wenyuan now holds 147.18 million unlisted shares (26.35% of total) and 30.81 million H shares (5.52%). No placee became a substantial shareholder, and the public float remains above the 25% regulatory threshold.

The placement was executed with at least six independent investors, and all conditions under the April 22 Placing Agreement were fulfilled on schedule.